GLURENORM

This brand name is authorized in Austria, Germany, Estonia, Croatia, Lithuania, Poland, Romania

Active ingredients

The drug GLURENORM contains one active pharmaceutical ingredient (API):

1 Gliquidone UNII C7C2QDD75P - GLIQUIDONE

Gliquidone is an anti-diabetic drug in the sulfonylurea class. It is used in the treatment of diabetes mellitus type 2. It is an ATP-dependent K+ (KATP) channel blocker. This block causes a depolarization which leads to activation of voltage-dependent Ca channels and Ca2+ influx, and eventually increases insulin release. Read about Gliquidone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10BB08	Gliquidone	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BB Sulfonamides, urea derivatives
Discover more medicines within A10BB08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 01675697, 01900786, 11166465, 12490274, 12496213, 14240274, 15587324
Country: EE	Ravimiamet	Identifier(s): 1879892, 1879904
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-740734183
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1000854
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100027266, 100376297, 100385698, 100409269
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W03352001